logo
logo

Emergence Therapeutics Raises €87 Million Series A Financing To Advance Nectin-4 Adc

Dec 07, 2021over 3 years ago

Amount Raised

€87 Million

Round Type

series a

Duisburg

Description

Emergence Therapeutics raises €87 million Series A financing to advance Nectin-4 ADC

Company Information

Company

Emergence

Location

Duisburg, Nordrhein-Westfalen, Germany

About

The company has made significant progress and the new funds provide the platform to drive the development of a substantial pipeline.” Emergence is also actively exploring opportunities to develop further first- or best-in-class ADCs driven by therapeutic need.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech